Two Covid-19 vaccines under trial potentially have more than 90% efficacy —PTF

0
127

The Presidential Task Force (PTF) on COVID-19, has stated that two Covid-19 vaccines under trial have more than 90 per cent efficacy of curing the deadly virus which has spread across the country.

This was revealed on Wednesday by Boss Mustapha, the Secretary to the Government of the Federation and chairman of the PTF on Covid-19 who expressed confidence that COVID-19 would soon be a thing of the past in the country.

The Chairman of the PTF who spoke in Abuja also urged Nigerians to take necessary precautions to avoid being infected with the deadly virus which has claimed many lives.

READ ALSO:ASUU strike: Public universities will soon reopen, FG assure Nigerians

The statement by the PTF noted that; “we have consciously taken steps to ensure that as a country our citizens do the needful to avoid being infected or infecting others with COVID-19 and with two vaccines under trial potentially having more than 90 per cent efficacy, I believe that ultimately there will be light at the end of the tunnel.

“Drawing from this, it is also very apt that Nigeria has chosen a theme: “United to end AIDS in the midst of COVID – 19: Get tested”.

“Nigeria as a country aligned fully with the global solidarity and shared responsibility, which requires us to view global health responses, including the AIDS response, in a new way,” the PTF statement concluded.

Watch Leakblast TV channel from around the world

Thanks for Reading via the most updated news portal

About Leakblast.com

Share your story with us

Advertise With us

Encourage & Support LeakBlast

Feel free to contact us

Call Us:+234(0)9073726403
Get us on Whatsapp: +234(0)8181166425      
Email Us: editors@leakblast.com

SUPPORT LEAKBLAST JOURNALISM OF INTEGRITY AND CREDIBILITY

Good  journalism costs a lot of money.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble Endeavor.

By contributing to LeakBlast, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Support LeakBlast

LEAVE A REPLY

Please enter your comment!
Please enter your name here